Skip to main content
Top
Published in: The Journal of Obstetrics and Gynecology of India 1/2016

01-02-2016 | Invited Mini Review

Pregnancy After Cardiac Surgery

Authors: Anjali Vivek Kanhere, Vivek Madhav Kanhere

Published in: The Journal of Obstetrics and Gynecology of India | Issue 1/2016

Login to get access

Abstract

Heart disease is one of the common, indirect obstetric causes of maternal death. Management of these cases may challenge the entire team providing care to the mother and fetus. Advances in cardiac surgery has improved quality of life and level of functioning of cardiovascular system of patients with congenital or acquired heart disease. These diseases complicate 0.1–4 % pregnancies. Maternal complications in the form of thromboembolic, hemorrhagic episode and heart failure may occur. The fetus is in danger of effects of oral anticoagulation therapy and other medications given to the patient in order to support cardiovascular system, intrauterine growth restriction and danger of hypoxia. In recent era, we are facing more pregnant patients with previous history of surgical correction of congenital or rheumatic heart disease. In this review, we have attempted to draw a management protocol of such patients based on the available literature and various international guidelines. In pregnant women with mechanical heart valves, recent data support warfarin use throughout pregnancy, followed by a switch to heparin and planned induction of labor. However, the complexity of this situation demands a cafeteria approach where the patient herself can choose from the available options that are supported by evidence-based information. Preconception counseling, evaluation and antenatal high-risk management protocol with the help of cardiologist and cardiac surgeon improves maternal and neonatal outcome.
Literature
1.
go back to reference Royal College of Obstetricians and Gynaecologists. Why mothers die 2000–2002—the sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG press; 2004. Royal College of Obstetricians and Gynaecologists. Why mothers die 2000–2002—the sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG press; 2004.
2.
go back to reference Plesinac S, Pilic I. Course and outcome of pregnancy after the heart surgery. In: Proceedings of the world medical conference Prague. September 2011. Plesinac S, Pilic I. Course and outcome of pregnancy after the heart surgery. In: Proceedings of the world medical conference Prague. September 2011.
3.
go back to reference Srivastava AP, Modi P, Sahi S, et al. Anticoagulation for pregnant patients. Ann Card Anesth. 2007;10:95–107.CrossRef Srivastava AP, Modi P, Sahi S, et al. Anticoagulation for pregnant patients. Ann Card Anesth. 2007;10:95–107.CrossRef
5.
go back to reference European Society of Gynecology (ESG), Association for European Pediatrics Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147.CrossRef European Society of Gynecology (ESG), Association for European Pediatrics Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147.CrossRef
6.
go back to reference Hirsh J, Dalen JE, Deykin D et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. In: Fourth ACCP consensus conference on antithrombotic therapy. Chest. 1995; 108(suppl):231S–246S. Hirsh J, Dalen JE, Deykin D et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. In: Fourth ACCP consensus conference on antithrombotic therapy. Chest. 1995; 108(suppl):231S–246S.
7.
go back to reference Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy clinical update. Circulation. 2003;107:1240–6.CrossRefPubMed Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy clinical update. Circulation. 2003;107:1240–6.CrossRefPubMed
10.
go back to reference Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57.CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57.CrossRefPubMed
12.
go back to reference Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systemic review of the literature. Arch Intern Med. 2000;160:191–6.CrossRefPubMed Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systemic review of the literature. Arch Intern Med. 2000;160:191–6.CrossRefPubMed
13.
go back to reference Sorin C. Juverdeanu surgical termination of pregnancy for maternal cardiac disease: a safer option? TMJ. 2009;59(2):169–72. Sorin C. Juverdeanu surgical termination of pregnancy for maternal cardiac disease: a safer option? TMJ. 2009;59(2):169–72.
14.
go back to reference Ray P, Murphy GJ. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004;93(3):428–39.CrossRefPubMed Ray P, Murphy GJ. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004;93(3):428–39.CrossRefPubMed
15.
go back to reference Gary M, Harrison J. Analysis of severe adverse events related to the use of mifepristone as an abortifacient. Ann Pharmacother. 2006;40(2):191–7.CrossRefPubMed Gary M, Harrison J. Analysis of severe adverse events related to the use of mifepristone as an abortifacient. Ann Pharmacother. 2006;40(2):191–7.CrossRefPubMed
16.
go back to reference Bonow RO, Carabello BA, Chatterjee K et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523–661.CrossRefPubMed Bonow RO, Carabello BA, Chatterjee K et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523–661.CrossRefPubMed
17.
go back to reference Gopalakrishnan S, Narayanan S. Oral anticoagulants: current Indian scenario. In: Medicine update. The Association of Physicians of India; 2013. p. 410–3. Gopalakrishnan S, Narayanan S. Oral anticoagulants: current Indian scenario. In: Medicine update. The Association of Physicians of India; 2013. p. 410–3.
18.
go back to reference Sibai BM. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150(7):831–5.CrossRefPubMed Sibai BM. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150(7):831–5.CrossRefPubMed
19.
go back to reference North RA, Hunt B, Gaasch WH et al. Management of pregnant women with prosthetic heart valves, 2015. North RA, Hunt B, Gaasch WH et al. Management of pregnant women with prosthetic heart valves, 2015.
20.
go back to reference Silversides CK. Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep. 2009;11:298–305.CrossRefPubMed Silversides CK. Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep. 2009;11:298–305.CrossRefPubMed
Metadata
Title
Pregnancy After Cardiac Surgery
Authors
Anjali Vivek Kanhere
Vivek Madhav Kanhere
Publication date
01-02-2016
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue 1/2016
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-016-0841-y

Other articles of this Issue 1/2016

The Journal of Obstetrics and Gynecology of India 1/2016 Go to the issue